Patents Assigned to AVENTI INC.
  • Publication number: 20230149326
    Abstract: A pharmaceutical or food composition including alverine, 4-hydroxy alverine, a derivative thereof, or a salt thereof and their uses are disclosed. The composition is useful for preventing, alleviating, or treating muscular weakness-related diseases. When myoblasts are treated with the alverine, 4-hydroxy alverine, derivative thereof, or salt thereof, differentiation into myotubes is promoted. Therefore, the alverine, 4-hydroxy alverine, derivative thereof, or salt thereof can be effectively used in the promotion of differentiation of myoblasts and the prevention, alleviation, or treatment of muscular weakness-related diseases.
    Type: Application
    Filed: April 9, 2021
    Publication date: May 18, 2023
    Applicant: AVENTI INC.
    Inventors: Ki-Sun KWON, Younglang LEE, Jong Hyun YOON, Seung-Min LEE, Chang Hoon JEON, Tai Hwan HA, Do Yeun JEONG